Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period

Internal Medicine

Volumn 50, Issue 9, 2011, Pages 975-981

  Kawano, Sayaka ^a   Kato, Johji ^b   Kawano, Noriaki ^b   Yoshimura, Yuki ^c   Masuyama, Hiroyuki ^c   Fukunaga, Takashi ^c   Sato, Yuichiro ^a   Maruyama, Haruhiko ^a   Mihara, Kenroh ^c   Ueda, Akira ^c   Toyoda, Kiyokazu ^c   Imamura, Takuroh ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

Author keywords

Eosinophilic cationic protein; Eosinophilic myocarditis; FIP1 L1 PDGFRa fusion gene; Parasitic infection; Prednisolone

Indexed keywords

ALBENDAZOLE; AMIODARONE; C REACTIVE PROTEIN; CREATINE KINASE; CREATININE; EOSINOPHIL CATIONIC PROTEIN; HEMOGLOBIN; IMATINIB; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PREDNISOLONE; UREA;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CHRONIC EOSINOPHILIC LEUKEMIA; CHRONIC LEUKEMIA; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY THROMBOSIS; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDITIS; EOSINOPHILIA; EOSINOPHILIC ENDOCARDITIS; EOSINOPHILIC MYOCARDITIS; FEMALE; FEVER; FIP 1 L1 PDGFRALPHA FUSION GENE; FUSION GENE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ASYNERGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE THROMBUS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE THROMBUS; HEART VENTRICLE ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; IDIOPATHIC DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LENGTH OF STAY; LIVER INJURY; LOW DRUG DOSE; LUNG THROMBOSIS; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; MALE; MYOCARDITIS; NEUROLOGIC DISEASE; PARASITOSIS; PERICARDIAL EFFUSION; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SURVIVAL TIME; SYSTOLIC HEART MURMUR; T WAVE; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TOXOCARA CANIS; TOXOCARIASIS; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHURG-STRAUSS SYNDROME; EOSINOPHILIA; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDITIS; PARASITIC DISEASES; PREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79955613562     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4079     Document Type: Article

References (26)

1. Aretz HT. Myocarditis: The Dallas criteria. Human Pathology 18: 619-624, 1987.
2. Okada R, Kawai S, Kasuya H. Nonspecific myocarditis. A statistical and clinicopathological study of autopsy cases. Jpn Circ J 53: 40-48, 1989.
3. Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J 65: 961-964, 2001.
4. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333: 269-275, 1995.
5. AM Al Ali, Straatman LP, Allard MF, Ignaszewski AP. Eosinophilic myocarditis: Case series and review of literature. Can J Cardiol 22: 1233-1237, 2006.
6. Ito T, Harada K, Takada G. An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventricular diastolic dysfunction observed by echocardiography. Dysfunction observed by echocardiography. Heart Vessels 13: 302-305, 1998.
7. Maruyoshi H, Nakatani S, Yasumura Y, et al. Lüffler's endocarditis associated with unusual ECG change mimicking posterior myocardial infarction. Heart Vessels 18: 43-46, 2003.
8. Hayashi S, Isobe M, Okubo Y, Suzuki J, Yazaki Y, Sekiguchi M. Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels 14: 104-108, 1999.
9. Arima M, Kanoh T, Kawano Y, Oigawa T, Yamagami S, Matsuda S. Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis. Int J Cardiol 84: 97-99, 2002.
10. Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ. Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 53: 1472-1473, 1984.
11. Ramakrishna G, Connolly HM, Tazelaar HD, Mullany CJ, Midthun DE. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis. Mayo Clin Proc 75: 631-635, 2000.
12. Arima M, Kanoh T. Eosinophilic myocarditis associated with dense deposits of eosinophil cationic protein (ECP) in endomyocardium with high serum ECP. Heart 81: 669-675, 1999.
13. Vaego TA, Singer DB, Gillatte PC, Fernbach DJ. Myocarditis due to visceral larva migrans. J Pediatr 90: 322-323, 1977.
14. Abe K, Shimokawa H, Kubota T, Nawa Y, Takishita A. Myocarditis associated with visceral larva migrans due to Toxocara canis. Intern Med 41: 706-708, 2002.
15. Enko K, Tada T, Ohgo KO, et al. Fulminant eosinophilic myocarditis associated with visceral larva migrans caused by Toxocara canis infection. Circ J 73: 1344-1348, 2009.
16. Vandenberghe P, Wlodarska I, Michaux L, et al. Clinical and molecular features of FIP1L1-PDGFRA(+) chronic eosinophilic leukemias. Leukemia 18: 734-742, 2004.
17. Kilon AD, Robyn J, Akin C, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 103: 473-478, 2004.
18. Rotoli B, Catalano L, Galderisi M, et al. Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma 45: 2503-2507, 2004.
19. Musial J, Brzezinska-Kolarz B, Sanak M, Szczeklik A. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib. Eur J Haematol 75: 87-88, 2005.
20. Starza RL, Specchia G, Cuneo A, et al. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4) (q 12)-FIP1L1-PDGFRA but not genomic rearrangements of other tyrosine kinases. Haematologica 90: 596-601, 2005.
21. Florian S, Esterbauer H, Binder T, et al. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRα, classification by WHO criteria, and response to therapy with imatinib. Leuk Res 30: 1201-1205, 2006.
22. Arai A, Yan W, Wakabayashi S, Hayashi S, Inazawa J, Miura O. Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilicleukemia followed by severe hepatotoxicity. Int J Hematol 86: 233-237, 2007.
23. Tai PC, Ackerman SJ, Spry CJF, Dunnette S, Olsen EGJ, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 8534: 643-647, 1987.
24. Japanese Circulation Society Task Force Committee on Acute and Chronic Myocarditis. Guidelines for diagnosis and treatment of myocarditis (JCS 2009), http://www.j-circ.or.jp/guideline/pdf/JCS2009_izumi_h.pdf.
25. Sato Y, Fukunaga T, Hayashi T, Asada Y. Hypereosinophilic syndrome associated with occlusive coronary thrombosis and right ventricular thrombus. Pathology International 58: 138-141, 2008.
26. Desreumaux P, Janin A, Dubucquoi S, et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart disease. Blood 82: 1553-1560, 1993.